FacebookTwitterRedditEmail

The Genocide Election

This election is about much more than Democrats or Republicans, higher or lower taxes, or the war in Iraq. It is about the survival of millions of people around the globe. And if candidates supported by the drug industry prevail, we may become participants in a silent genocide.

A few years ago I attended a closed meeting with consultants for Ernst & Young. They told the gathered drug executives that the pharma industry was in trouble. Ernst & Young had added together the sales forecasts the industry had given to Wall Street and they told us, “If you are going to meet those numbers, you need twice as many drugs as you have in your pipeline. Your stock is going to fall off a cliff during the next ten years.”

Today, that prediction has come true. Drug company stocks have tumbled. The biggest drug company, Pfizer, has lost 40% of its value in the last five years.

The only temporary relief has been the Medicare prescription benefit. According to the New York Times, this program has raised profits for drug makers both by increasing the prices they receive and by encouraging beneficiaries to fill prescriptions they might otherwise have been unable to afford.

Democrats claim the government could save as much as $190 billion over the next 10 years if the Medicare program was allowed to negotiate prices directly with drug manufacturers.

But losing the election to Democrats isn’t the only threat looming on the horizon for the drug industry. IMS Health, an industry research firm, estimates prescription drugs worth $121.5 billion will come off patent between 2006 and 2011. That’s half of U.S. drug sales.

But the drug company CEO’s have a plan to fix all these problems. Just like a bad student might contemplate cheating, the drug industry plans on big scale cheating.

Number one on the cheat sheet is to stop generics from coming onto the market, in the U.S and overseas. One such failed attempt recently resulted in the ouster of Peter Dolan, Bristol-Myers Squibb Co.’s former CEO. This sordid affair also led to the FBI searching his office. But it wasn’t the FBI the board was disturbed about when they fired Mr. Dolan. They were upset about the fact that Mr. Dolan failed to buy off the generic drug maker, and messed up so badly that the generic company was able to temporarily flood the U.S. market with the cheap generic drug he’d tried to stop.

According to the Washington Post, “The brand-name drug industry is aggressively working to keep blockbuster drugs widely used by the elderly from being sold in cheaper generic versions when their patents expire.”

Pfizer’s recently ousted CEO, Dr. Hank McKinnell, in his book “A Call to Action” is very clear on the drug industry’s objective: He calls for a doubling of drug patent life [page 185] which would result in a drastic reduction of new, low-priced generic drugs.

And what should be our concern is that these dirty deals aren’t just taking place in the U.S. The drug industry is also using the current administration to do their bidding and deny affordable drugs to the poorest countries in the world.

According to the International Herald Tribune, the White House is pushing bilateral and regional trade agreements in which poor countries are forced to enact “superpatents’ that prolong U.S. drug makers’ monopolies and limit the circumstances under which the patents can be broken.

Pedro Chequer, the head of Brazil’s national AIDS program has said: “If you prevent countries from using generic drugs, you are creating a concrete obstacle to providing access to drugs. You are promoting genocide, because you’re killing people.”

The trade deals are often negotiated in secret and attract little notice. But they have already been signed with poor countries overwhelmed by AIDS, among them six in Central America. And negotiations have started with several nations that also are overwhelmed by the AIDS virus, from Thailand to five southern African countries, including South Africa and Botswana.

When a life-saving industry cheats, people die. When the White House participates in these dirty deals, the result may be genocide.

Peter Rost, M.D., is a former Vice President of Pfizer. He became well known in 2004 when he emerged as the first drug company executive to speak out in favor of reimportation of drugs. He is the author of “The Whistleblower, Confessions of a Healthcare Hitman.” See: http://the-whistleblower-by-peter-rost.blogspot.com/

 

 

More articles by:
August 12, 2020
Melvin Goodman
Trump’s War On Arms Control and Disarmament
P. Sainath
“We Didn’t Bleed Him Enough”: When Normal is the Problem
Riva Enteen
Kamala Harris? Really? Desperate Times, Desperate Measures
Kenneth Surin
The Decrepit UK Political System
Robert Hunziker
Freakish Arctic Fires Alarmingly Intensify
Ramzy Baroud
The Likud Conspiracy: Israel in the Throes of a Major Political Crisis
Sam Pizzigati
Within Health Care USA, Risk and Reward Have Never Been More Out of Kilter
John Perry
The US Contracts Out Its Regime Change Operation in Nicaragua
Binoy Kampmark
Selective Maritime Rules: The United States, Diego Garcia and International Law
Manuel García, Jr.
The Improbability of CO2 Removal From the Atmosphere
Khury Petersen-Smith
The Road to Portland: The Two Decades of ‘Homeland Security’
Raouf Halaby
Teaching Palestinian Children to Love Beethoven, Bizet, and Mozart is a Threat to a Depraved Israeli Society
Jeff Mackler
Which Way for Today’s Mass Radicalization? Capitalism’s Impending Catastrophe…or a Socialist Future
Tom Engelhardt
It Could Have Been Different
Stephen Cooper
Santa Davis and the “Stalag 17” Riddim
August 11, 2020
Richard D. Wolff
Why Capitalism is in Constant Conflict With Democracy
Paul Street
Defund Fascism, Blue and Orange
Richard C. Gross
Americans Scorned
Andrew Levine
Trump and Biden, Two Ignoble Minds Here O’erthrown
Patrick Cockburn
The Rise of Nationalism Has Led to the Increased Repression of Minorities
Sonali Kolhatkar
Trump’s Presidency is a Death Cult
Colin Todhunter
Pushing GMO Crops into India: Experts Debunk High-Level Claims of Bt Cotton Success
Valerie Croft
How Indigenous Peoples are Using Ancestral Organizing Practices to Fight Mining Corporations and Covid-19
David Rovics
Tear Gas Ted Has a Tantrum in Portland
Dean Baker
There is No Evidence That Generous Unemployment Benefits are Making It Difficult to Find Workers
Robert Fantina
War on Truth: How Kashmir Struggles for Freedom of Press
Dave Lindorff
Trump Launches Attack on Social Security and Medicare
Elizabeth Schmidt
COVID-19 Poses a Huge Threat to Stability in Africa
Parth M.N.
Coping With a Deadly Virus, a Social One, Too
Thomas Knapp
The “Election Interference” Fearmongers Think You’re Stupid
Binoy Kampmark
Mealy-Mouthed Universities: Academic Freedom and the Pavlou Problem Down Under
Mike Garrity
Emperor Trump Loses Again in the Northern Rockies in Big Win for Bull Trout, Rivers and the ESA
Alex Lawson
34 Attorneys General Call to Bust Gilead’s Pharma Monopoly on COVID Treatment Remdesivir
August 10, 2020
Gerald Sussman
Biden’s Ukrainegate Problem
Vijay Prashad – Érika Ortega Sanoja
How the U.S. Failed at Its Foreign Policy Toward Venezuela
Daniel Warner
Geneva: The Home of Lost Causes
Mike Hastie
The Police Force Stampede in Portland on August 8, 2020 
Jack Rasmus
Trump’s Executive Orders: EOs as PR and FUs
Rev. William Alberts
Cognitive Without Conscience
David Altheide
Politicizing Fear Through the News Media
F. Douglas Stephenson
Is Big Pharma More Interested in Profiteering Than Protecting Us From Coronavirus?
Evaggelos Vallianatos
The Money Plague
Howard Lisnoff
Revolutionaries Living in a System of Growing Fascism
Ralph Nader
Donald Trump is Defeating Himself
Lynnette Grey Bull
The Murdered and Missing Indigenous Women Human Rights Emergency is Not a Photo-Op for Ivanka Trump
FacebookTwitterRedditEmail